Medical Cannabis: Implications for Prescription Drugs, Health Care and Consumer Goods
New insights for key industries impacted by the growth of medical marijuana into the reasons why patients choose cannabis as an alternative or addition to other health-and-wellness products
About
Illinois was the 20th state to establish a medical-marijuana program. The growing wave of legalization and normalization of cannabis usage has resulted in changing consumer attitudes and behaviors. Patients have begun to swap certain health-and-wellness products for medical marijuana. This trend is at its beginning and its impact on prescription drugs and countless items in the health-and-wellness aisles is only going to grow.
Objectives
- Identify characteristics of cannabis patients (in Illinois) and why they are using medical marijuana
- Understand how medical cannabis impacts prescription-drug usage
- Quantify the methods (vaping, edibles, etc.) patients use to consume medical cannabis for symptom relief
- Analyze the overall shopping experience of selecting and buying medical cannabis products
- Learn from Illinois as a roadmap for future expanded medical marijuana use as a result of its highly stringent regulations
Why?
Within this study of a single medical cannabis market, you'll discover key need states that drive cannabis consumption and impact more than 130-million adults impacted by chronic-pain conditions.
This study of Illinois -- one of the most restrictive medical-cannabis states in the country -- illuminates usage trends with far-reaching implications across adjacent categories and services:
• OTC medications ($34 billion – 2016 retail sales - CHPA)
• Vitamin supplements ($27.6 billion – 2016 retail sales – Euromonitor)
• Prescription drugs ($424 billion – 2015 retail, mail & amp; non-retail sales – IMS Health)
• In-store pharmacy retailers ($208 billion – 2015 chain, independents & grocery store pharmacies – IMS)
Email info@collaborata.com to schedule a call with the research leaders. (Click link below to read National Pain Report article about this study: http://nationalpainreport.com/illinois-medical-cannabis-patient-study-shows-positive-impact-on-pain-8833677.html)
Within this study of a single medical cannabis market, you'll discover key need states that drive cannabis consumption and impact more than 130-million adults impacted by chronic-pain conditions.
This study of Illinois -- one of the most restrictive medical-cannabis states in the country -- illuminates usage trends with far-reaching implications across adjacent categories and services:
• OTC medications ($34 billion – 2016 retail sales - CHPA)
• Vitamin supplements ($27.6 billion – 2016 retail sales – Euromonitor)
• Prescription drugs ($424 billion – 2015 retail, mail & amp; non-retail sales – IMS Health)
• In-store pharmacy retailers ($208 billion – 2015 chain, independents & grocery store pharmacies – IMS)
Email info@collaborata.com to schedule a call with the research leaders. (Click link below to read National Pain Report article about this study: http://nationalpainreport.com/illinois-medical-cannabis-patient-study-shows-positive-impact-on-pain-8833677.html)
Methodology: Qualitative/Quantitative
Qualitative Design
Number of research sessions (or interviews) by specific approach:
Aclara Research partnered with medical cannabis patient social-media groups to conduct this research. These groups focus on medical cannabis usage but also include adult use consumers .
We explored qualitative insights across key focus areas and invited members to respond. Topics included:
• Doctor and patient communication
• Commonly experienced symptoms
• Perceived product efficacy
• Retail experience and product selection
Qualitative Research Target
Gender: 40% Male, 60% Female
Ages: 18 to 80
Behavioral/Lifestyle Screening:
Medical cannabis patients within the state of Illinois
Number of Markets: 1
Quantitative Design
Number of Interviews: 300
Interview Length: 11 minutes
Quantitative Research Target
Gender: 40% Male, 60% Female
Ages: 18 to 81
Behavioral/Lifestyle Screening:
Medical Cannabis patients within the state of Illinois
Deliverables
Reporting: Summary Report
Presentation: Web-based
Additional Deliverables:
The Aclara team offers a webinar presentation to each subscriber of the study. In addition, clients may contact Aclara Research to present the study in person (Aclara will bill additionally for the presentation). .
Per-diem and travel expenses will be billed additionally for an in-person presentation of findings.
Timing: Available Immediately
Supplier
Company: Aclara Research
Previous Projects: 1
Rating: Supplier has not been rated
Supplier's Qualifications:
Aclara Research is a team of consulting professionals linking cannabis patient and consumer insights with healthcare research to solve commercial challenges. Aclara insights illuminate market opportunities, product development, and business strategy through ongoing engagement with our research panel of cannabis patients and consumers across legal cannabis markets. Learn more about Aclara Research by clicking https://www.aclararesearch.com
-3af9729f51fe0684b7602468fd54ee9c4acc8c5ffaaa3cc6ad661984c5290e99.png)
Add Comment